Cytotoxic CD8-positive T-lymphocyte infiltration in the lungs as a histological pattern of SARS-CoV-2 pneumonitis.


Journal

Pathology
ISSN: 1465-3931
Titre abrégé: Pathology
Pays: England
ID NLM: 0175411

Informations de publication

Date de publication:
Jun 2022
Historique:
received: 18 06 2021
revised: 05 08 2021
accepted: 06 09 2021
pubmed: 28 11 2021
medline: 7 6 2022
entrez: 27 11 2021
Statut: ppublish

Résumé

Despite millions of PCR confirmed cases of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection, the long-term pathophysiological changes induced by this infection in the lungs and their relationship with possible immune triggers remain incompletely understood. Acute respiratory distress syndrome and subsequent respiratory failure are the most common causes of mortality in hospitalised patients. Severe lung tissue destruction can be due to an overactive immune system that far exceeds the harm that would have been caused by direct virus replication. This study extends our previous investigation and presents detailed histopathological findings on cryotransbronchial biopsy in patients with persistent (range 31-182 days) pneumonitis and severe interstitial inflammatory infiltration in the lungs due to SARS-CoV-2 infection. We describe a novel lung injury pattern associated with SARS-CoV-2 pneumonitis, which manifests as a marked interstitial CD8-positive T-cell lymphocytic infiltration. These findings provide a better understanding of the changes in the lungs that ensue due to SARS-CoV-2 infection.

Identifiants

pubmed: 34836647
pii: S0031-3025(21)00514-6
doi: 10.1016/j.pathol.2021.09.005
pmc: PMC8572726
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

404-408

Informations de copyright

Copyright © 2021 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.

Références

J Virol. 2010 Sep;84(18):9318-25
pubmed: 20610717
Lancet Respir Med. 2020 Aug;8(8):807-815
pubmed: 32422178
Cell. 2020 Dec 23;183(7):1901-1912.e9
pubmed: 33248470
Pathol Res Pract. 2021 Apr;220:153380
pubmed: 33676105
Emerg Infect Dis. 2005 Nov;11(11):1730-7
pubmed: 16318725
Cytokine Growth Factor Rev. 2020 Jun;53:25-32
pubmed: 32446778
Nat Med. 2020 Oct;26(10):1636-1643
pubmed: 32839624
Lancet Respir Med. 2020 Apr;8(4):420-422
pubmed: 32085846
Eur Respir J. 2020 Jul 2;56(1):
pubmed: 32398298
Lancet. 2020 Mar 28;395(10229):1054-1062
pubmed: 32171076
Front Immunol. 2020 Jun 16;11:1446
pubmed: 32612617

Auteurs

Andrii Puzyrenko (A)

Medical College of Wisconsin, Pathology Department, Milwaukee, WI, USA. Electronic address: apuzyrenko@mcw.edu.

Juan C Felix (JC)

Medical College of Wisconsin, Pathology Department, Milwaukee, WI, USA.

Nathan A Ledeboer (NA)

Medical College of Wisconsin, Pathology Department, Milwaukee, WI, USA.

Yunguang Sun (Y)

Medical College of Wisconsin, Pathology Department, Milwaukee, WI, USA.

Hallgeir Rui (H)

Medical College of Wisconsin, Pathology Department, Milwaukee, WI, USA.

Yuri Sheinin (Y)

Medical College of Wisconsin, Pathology Department, Milwaukee, WI, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH